The House Committee on Economic Development, Small Business, and Trade convened on March 26, 2025, to discuss significant advancements in Oregon's healthcare technology sector. The meeting highlighted innovative developments from local startups, particularly focusing on the integration of advanced sensing technologies in medical procedures.

One of the key presentations came from a representative of a company developing wireless sensors designed for monitoring critical load measurements in reconstructed soft tissue grafts, such as those used in ACL and rotator cuff surgeries. The device, which utilizes proprietary wireless sensing technology licensed from the University of Oregon, aims to provide real-time feedback during and after surgical procedures. This capability is expected to enhance the efficiency and accessibility of healthcare, particularly during rehabilitation. The company has received FDA breakthrough device designation and is currently in the preclinical phase, with plans for regulatory submission anticipated within the next one to two years.

The meeting also featured John Harkness, CEO of Rewire AI, a startup specializing in artificial intelligence tools for biomedical imaging. Harkness expressed strong support for House Bill 2417 and the continued funding of Oregon's Centers of Innovation Excellence, which play a crucial role in fostering economic growth and job creation in the bioscience sector. He emphasized how the support from the Oregon Bioscience Incubator has been instrumental in Rewire's success, providing essential resources such as mentorship and networking opportunities.

Both presentations underscored the importance of state support and funding in nurturing innovative startups that contribute to Oregon's economy and healthcare advancements. The committee's discussions reflect a commitment to enhancing the state's bioscience industry, which is poised for growth through continued investment and collaboration among local institutions and businesses.